Logo image of USBC

USBC INC (USBC) Stock Fundamental Analysis

USA - NYSEARCA:USBC - US4992382022 - Common Stock

0.91 USD
+0.02 (+2.27%)
Last: 9/19/2025, 8:04:00 PM
0.8905 USD
-0.02 (-2.14%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

0

Taking everything into account, USBC scores 0 out of 10 in our fundamental rating. USBC was compared to 191 industry peers in the Health Care Equipment & Supplies industry. USBC has a bad profitability rating. Also its financial health evaluation is rather negative. USBC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

USBC had negative earnings in the past year.
USBC had a negative operating cash flow in the past year.
USBC had negative earnings in each of the past 5 years.
In the past 5 years USBC always reported negative operating cash flow.
USBC Yearly Net Income VS EBIT VS OCF VS FCFUSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

USBC has a Return On Assets of -3181.63%. This is amonst the worse of the industry: USBC underperforms 98.95% of its industry peers.
Industry RankSector Rank
ROA -3181.63%
ROE N/A
ROIC N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USBC Yearly ROA, ROE, ROICUSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for USBC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
USBC Yearly Profit, Operating, Gross MarginsUSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, USBC has more shares outstanding
The debt/assets ratio for USBC is higher compared to a year ago.
USBC Yearly Shares OutstandingUSBC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
USBC Yearly Total Debt VS Total AssetsUSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

USBC has an Altman-Z score of -463.83. This is a bad value and indicates that USBC is not financially healthy and even has some risk of bankruptcy.
USBC has a Altman-Z score of -463.83. This is amonst the worse of the industry: USBC underperforms 96.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -463.83
ROIC/WACCN/A
WACCN/A
USBC Yearly LT Debt VS Equity VS FCFUSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 0.03 indicates that USBC may have some problems paying its short term obligations.
The Current ratio of USBC (0.03) is worse than 97.38% of its industry peers.
A Quick Ratio of 0.03 indicates that USBC may have some problems paying its short term obligations.
USBC has a Quick ratio of 0.03. This is amonst the worse of the industry: USBC underperforms 97.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
USBC Yearly Current Assets VS Current LiabilitesUSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.83% over the past year.
Looking at the last year, USBC shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)42.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.89%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, USBC will show a small growth in Earnings Per Share. The EPS will grow by 1.18% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
USBC Yearly Revenue VS EstimatesUSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2026 2M 4M 6M
USBC Yearly EPS VS EstimatesUSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

USBC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year USBC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USBC Price Earnings VS Forward Price EarningsUSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USBC Per share dataUSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.56%
EPS Next 3Y1.18%

More info and screens

0

5. Dividend

5.1 Amount

USBC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

USBC INC

NYSEARCA:USBC (9/19/2025, 8:04:00 PM)

After market: 0.8905 -0.02 (-2.14%)

0.91

+0.02 (+2.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05
Earnings (Next)11-12 2025-11-12/amc
Inst Owners1.32%
Inst Owner ChangeN/A
Ins Owners8.64%
Ins Owner ChangeN/A
Market Cap349.65M
Analysts82.86
Price TargetN/A
Short Float %5.02%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.03
EYN/A
EPS(NY)-9.38
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3181.63%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-196.65%
ROA(5y)N/A
ROE(3y)-930.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z -463.83
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)144.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.89%
EPS Next Y25%
EPS Next 2Y8.56%
EPS Next 3Y1.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-49.63%
OCF growth 3YN/A
OCF growth 5YN/A